217 related articles for article (PubMed ID: 4876837)
1. Measures to reduce the serum lipid levels in coronary heart disease.
Connor WE
Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837
[No Abstract] [Full Text] [Related]
2. Control of biochemical precursors of coronary heart disease.
Ostrander LD
Geriatrics; 1969 Dec; 24(12):61-6. PubMed ID: 5353631
[No Abstract] [Full Text] [Related]
3. Treatment of hyperlipidemic states.
Strisower EH; Adamson G; Strisower B
Med Clin North Am; 1970 Nov; 54(6):1599-613. PubMed ID: 5487683
[No Abstract] [Full Text] [Related]
4. Management of the hyperlipidemic patient.
Berkowitz D
Med Clin North Am; 1973 Jul; 57(4):881-92. PubMed ID: 4576152
[No Abstract] [Full Text] [Related]
5. Lipid lowering agents.
Br Med J; 1972 Jun; 2(5814):642-3. PubMed ID: 5031693
[No Abstract] [Full Text] [Related]
6. The use of pharmacologic agents in atherosclerosis therapy.
Kritchevsky D
Ann N Y Acad Sci; 1968 Nov; 149(2):1058-68. PubMed ID: 4890515
[No Abstract] [Full Text] [Related]
7. Are massive diet fat heart and coronary drug studies justified? A critical commentary.
Roberts HJ
Angiology; 1968 Dec; 19(11):652-64. PubMed ID: 4317984
[No Abstract] [Full Text] [Related]
8. [Hyperlipidemia and coronary disease].
Krikler DM
Coeur Med Interne; 1976; 15(1):3-10. PubMed ID: 793762
[No Abstract] [Full Text] [Related]
9. Treatment of essential hyperlipidaemia.
Jepson EM; Fahmy MF; Torrens PE; Billimoria JD; Maclagan NF
Lancet; 1969 Dec; 2(7634):1315-9. PubMed ID: 4188089
[No Abstract] [Full Text] [Related]
10. Therapy of lipid disorders.
Krikler DM
J Clin Pathol Suppl (Assoc Clin Pathol); 1973; 5():72-7. PubMed ID: 4582173
[No Abstract] [Full Text] [Related]
11. [Therapy of primary hyperlipemias].
Schlierf G; Kahlke W
Dtsch Med Wochenschr; 1969 Feb; 94(7):329-32. PubMed ID: 5762992
[No Abstract] [Full Text] [Related]
12. [Medical treatment of hyperlipemia. Indications and modern preparations].
Frey H
Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311
[No Abstract] [Full Text] [Related]
13. Treatment of hypercholesteremia and hypertriglyceridemia.
Albrink MJ
JAMA; 1969 Jan; 207(4):763. PubMed ID: 5818205
[No Abstract] [Full Text] [Related]
14. Classification of hyperlipidaemias.
Lewis B
Proc R Soc Med; 1971 Sep; 64(9):905-8. PubMed ID: 5114287
[No Abstract] [Full Text] [Related]
15. Long-term changes of serum cholesterol with cholesterol-altering drugs in patients with coronary heart disease. Veterans Administration Drug-Lipid Cooperative Study.
Detre KM; Shaw L
Circulation; 1974 Nov; 50(5):998-1005. PubMed ID: 4609636
[No Abstract] [Full Text] [Related]
16. [Diet and drug therapy of hyperlipoproteinemia].
Sirtori C
Minerva Med; 1975 Nov; 66(79):4184-5. PubMed ID: 1196507
[No Abstract] [Full Text] [Related]
17. The use of lipolytic drugs.
Geill T
Gerontol Clin (Basel); 1965; 7(6):321-9. PubMed ID: 5871676
[No Abstract] [Full Text] [Related]
18. Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy.
Casdorph HR
Angiology; 1970 Nov; 21(10):654-60. PubMed ID: 5480092
[No Abstract] [Full Text] [Related]
19. New drugs for the treatment of hypercholesterolemia.
Hamlin JT
Va Med Mon (1918); 1969 Jan; 96(1):11-2. PubMed ID: 5763103
[No Abstract] [Full Text] [Related]
20. Diet and drug therapy for hyperlipoproteinemia.
Maha GE
Med Times; 1971 Aug; 99(8):49-63 passim. PubMed ID: 5566828
[No Abstract] [Full Text] [Related]
[Next] [New Search]
